MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JK-19-0005781
Abinza Pharma Private Limited
Abinza Pharma Private Limited - pharma in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹58,215
Latest filing
Net profit · FY 2024
₹58,215
Net margin 100%
EBITDA · FY 2024
₹58,215
EBITDA margin 100%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹22.1 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Abinza Pharma Private Limited
Data last updated:
Abinza Pharma Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24233JK2021PTC012734. Its GSTIN is 01AAVCA8107E1ZV (Jammu and Kashmir).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Sanjeev Goel and Vishav Nath Jindal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Abinza Pharma Pvt. Ltd. SIDCO Phase – 1, Igc Samba, Jammu, Jammu and Kashmir, India – 184121.
As per the financials filed for FY 2024, the company reported a revenue of ₹58,215. For the same year it recorded a net profit of ₹58,215 (net margin 100%) and EBITDA of ₹58,215 (EBITDA margin 100%).
As per MCA filings, the company has open charges of ₹22.1 Cr on record.
Abinza Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-19-0005781). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233JK2021PTC012734
Registration Number 012734
Incorporation Date 20 September 2021
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JK-19-0005781
Key People
Sanjeev Goel Director Vishav Nath Jindal Director Recognitions & Rankings of Abinza Pharma
Contact details
Abinza Pharma Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Abinza Pharma Pvt. Ltd. SIDCO Phase – 1, Igc Samba, Jammu, Jammu and Kashmir, India – 184121
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Abinza Pharma Private Limited, buy the company report.
Comprehensive company report
Abinza Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Abinza Pharma Private Limited
FY 2025 filings availableAbinza Pharma Private Limited reported revenue of ₹58,215 for FY 2024.
Revenue · FY 2024
₹58,215
Net profit · FY 2024
₹58,215 margin 100%
EBITDA · FY 2024
₹58,215 margin 100%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹58,215 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹58,215 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 100% | ||
| Net Profit Margin | 100% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Abinza Pharma Private Limited, buy the company report.
Board of directors of Abinza Pharma Private Limited
Abinza Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Goel Also directs: Nuveda Research & Labs LLP, Ivcure Pharma Private Limited, Scorda Pharma Private Limited and 5 more | Director | 24 Dec 2021 | 4 Years 10 Months | Current |
| Vishav Nath Jindal Also directs: Ivcure Pharma Private Limited, Scorda Pharma Private Limited, Aanvis Pharma Private Limited and 2 more | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Abinza Pharma Private Limited is audited by CHANDER SHEKHAR AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHANDER SHEKHAR AND ASSOCIATES | FY 2023 | 020828N |
Shareholding
The shareholding of Abinza Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Abinza Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jul 2023 | 100745886 | Hdfc Bank Limited | ₹22.1 Cr | Open |
To see the full charge records of Abinza Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Abinza Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abinza Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Abinza Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Abinza Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAVCA8107E1ZV | Jammu and Kashmir | Active | 04 Nov 2022 |
To see the full GST registrations and return filing status of Abinza Pharma Private Limited, buy the company report.
Recent activity
Abinza Pharma Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Dhiraj Kumar ceased to be Director on 25 Dec 2021.
AGM
Abinza Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 22.10 Cr registered on 12 Jul 2023 with Charge ID 100745886 was modified on 28 Aug 2025.
Filing
Abinza Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 22.10 Cr with Charge ID 100745886 was registered on 12 Jul 2023.
Ceased
Dhiraj Kumar ceased to be Director.
Ceased
Mrinal Baidyanath ceased to be Director.
Ceased
Munesh Kumar ceased to be Director.
Appointed
Sanjeev Goel was appointed as Director.
Appointed
Vishav Nath Jindal was appointed as Director.
Incorporation
20 Sep 2021
Abinza Pharma Private Limited was registered on 20 Sep 2021 with Roc Jammu & aged 5 years 1 month as per MCA records.
Frequently asked questions
Abinza Pharma is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2021 (5+ years old) and is registered under CIN U24233JK2021PTC012734.
Abinza Pharma has 2 current directors:
- Sanjeev Goel - Director
- Vishav Nath Jindal - Director
The latest financial statements of Abinza Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Abinza Pharma is 01AAVCA8107E1ZV, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Abinza Pharma is U24233JK2021PTC012734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abinza Pharma was incorporated on 20 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jammu.
Dhiraj Kumar ceased to be Director on 25 Dec 2021. Mrinal Baidyanath ceased to be Director on 25 Dec 2021. Munesh Kumar ceased to be Director on 25 Dec 2021. Abinza Pharma has 5 board changes on record in total.
Yes, Abinza Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-19-0005781).
The registered office of Abinza Pharma is at CO Abinza Pharma Pvt. Ltd. SIDCO Phase – 1, Igc Samba, Jammu, Jammu and Kashmir, India – 184121.
Abinza Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages